NCT00005044 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 752
- group Id
- BG001
- value
- 737
- group Id
- BG002
- value
- 1489
- units
- Participants
- groups
- description
- Total Androgen Suppression (TAS) (LHRH agonist and Casodex or Eulexin) x 8 weeks followed by radiation therapy (RT) with concurrent TAS (LHRH agonist and Casodex or Eulexin).
- id
- BG000
- title
- TAS x 8 Weeks
- description
- TAS (LHRH agonist and Casodex or Eulexin) x 28 weeks followed by RT with concurrent TAS (LHRH agonist and Casodex or Eulexin).
- id
- BG001
- title
- TAS x 28 Weeks
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 45
- upper Limit
- 84
- value
- 71
- group Id
- BG001
- lower Limit
- 46
- upper Limit
- 88
- value
- 71
- group Id
- BG002
- lower Limit
- 45
- upper Limit
- 88
- value
- 71
- dispersion Type
- FULL_RANGE
- param Type
- MEDIAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Female
- measurements
- group Id
- BG000
- value
- 752
- group Id
- BG001
- value
- 737
- group Id
- BG002
- value
- 1489
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- population Description
- Eligible patients with follow-up data
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 752
- group Id
- BG001
- value
- 737
- group Id
- BG002
- value
- 1489
- units
- Participants
- groups
- description
- Total Androgen Suppression (TAS) (LHRH agonist and Casodex or Eulexin) x 8 weeks followed by radiation therapy (RT) with concurrent TAS (LHRH agonist and Casodex or Eulexin).
- id
- BG000
- title
- TAS x 8 Weeks
- description
- TAS (LHRH agonist and Casodex or Eulexin) x 28 weeks followed by RT with concurrent TAS (LHRH agonist and Casodex or Eulexin).
- id
- BG001
- title
- TAS x 28 Weeks
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 45
- upper Limit
- 84
- value
- 71
- group Id
- BG001
- lower Limit
- 46
- upper Limit
- 88
- value
- 71
- group Id
- BG002
- lower Limit
- 45
- upper Limit
- 88
- value
- 71
- dispersion Type
- FULL_RANGE
- param Type
- MEDIAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Female
- measurements
- group Id
- BG000
- value
- 752
- group Id
- BG001
- value
- 737
- group Id
- BG002
- value
- 1489
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- population Description
- Eligible patients with follow-up data
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle